United States  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Troubled Chandler pharma company sells off drug assets as part of bankruptcy

bizjournals Friday, 23 August 2019
Insys Therapeutics Inc, has entered into sales agreements to unload some of its drug assets for a combined $29.2 million as the Chandler-based pharmaceutical firm works through bankruptcy filing proceedings. Insys will sell its naloxone and epinephrine nasal sprays and related assets and equipment to Hikma Pharmaceuticals USA Inc. for $17 million, according to a filing with the Securities and Exchange Commission. Per the purchase agreement, Eatontown, New Jersey- based Hikma agreed to be responsible…

Recent related videos from verified sources

Charge Sacklers as "criminal drug dealers": lawmaker [Video]Charge Sacklers as "criminal drug dealers": lawmaker

Rep. Max Rose says he wants the Sackler family charged as criminal drug dealers. The Sacklers' firm, Purdue Pharma, declared Chapter 11 bankruptcy protection on Sunday, succumbing to pressure..

Credit: Rumble     Duration: 00:50Published

Purdue Pharma Files for Bankruptcy [Video]Purdue Pharma Files for Bankruptcy

Purdue Pharma Files for Bankruptcy . The maker of OxyContin filed for Chapter 11 bankruptcy protection on Sunday. . A tentative settlement was made last week with more than 2,000 local..

Credit: Wibbitz Top Stories     Duration: 01:43Published

Recent related news from verified sources

Purdue Pharma files for bankruptcy as part of settlement

Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching...

After bankruptcy filing, Purdue Pharma may not be off hook

OxyContin maker Purdue Pharma and its owners expressed sympathy but not responsibility for the nation's opioid crisis as the company filed for bankruptcy...

You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.